KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,680 | -70.3% | 30,200 | -52.3% | 0.01% | -64.7% |
| Q3 2022 | $346,000 | +16.5% | 63,328 | -3.9% | 0.02% | +41.7% |
| Q2 2022 | $297,000 | -62.8% | 65,928 | -39.1% | 0.01% | -58.6% |
| Q1 2022 | $799,000 | +505.3% | 108,228 | +757.1% | 0.03% | +480.0% |
| Q1 2021 | $132,000 | -35.0% | 12,627 | +17.7% | 0.01% | -54.5% |
| Q2 2020 | $203,000 | -81.1% | 10,728 | -80.8% | 0.01% | -87.1% |
| Q1 2020 | $1,072,000 | -42.9% | 55,800 | -43.0% | 0.08% | -18.3% |
| Q4 2019 | $1,878,000 | +255.0% | 97,900 | +78.0% | 0.10% | +205.9% |
| Q3 2019 | $529,000 | – | 55,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |